Lynx1 Capital Management »

Cg Oncology shares owned by Lynx1 Capital Management

Quarter-by-quarter ownership of Cg Oncology (CGON) shares owned by Lynx1 Capital Management from 13F filings

Historical chart of Lynx1 Capital Management investment in Cg Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cg Oncology held by Lynx1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cg Oncology by Lynx1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.3M 32k 41.52

More positions owned by Lynx1 Capital Management

Stoke Therapeutics (STOK)
Gh Research Ordinary Shares (GHRS)
Cullinan Oncology (CGEM)
Denali Therapeutics (DNLI)
C4 Therapeutics Com Stk (CCCC)
Xencor (XNCR)
Immatics SHS (IMTX)
Tscan Therapeutics (TCRX)
Passage Bio Com New (PASG)
Korro Bio (KRRO)
Precision Biosciences Com New (DTIL)
Neuphoria Therapeutics (NEUP)
Agios Pharmaceuticals (AGIO)
Cg Oncology (CGON)
Arrowhead Pharmaceuticals (ARWR)

View all positions for Lynx1 Capital Management

Top funds holding Cg Oncology

Vanguard Group
Decheng Capital
Wellington Management Company
BlackRock
FMR
TCG Crossover Management
State Street Corporation
Foresite Capital Management VI
Alliancebernstein
Rtw Investments
UBS Group
Braidwell
OrbiMed Advisors
Franklin Resources
Seven Fleet Capital Management

View all funds holding Cg Oncology